Cytokine production by synovial T cells in rheumatoid arthritis

Rheumatology

Volumn 38, Issue 3, 1999, Pages 202-213

  Steiner, G ^a,b   Tohidast Akrad, M ^b   Witzmann, G ^b   Vesely, M ^b   Studnicka Benke, A ^b   Gal, A ^c   Kunaver, M ^d   Zenz, P ^e   Smolen, J S ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b GENERAL HOSPITAL LINZ   (Austria)

^c National Institute of Rheumatology Budapest   (Hungary)

^d Department of Surgery   (Austria)

^e Hospital Baumgartner Hohe   (Austria)

Author keywords

Cytokines; IFN ; IL 4; Osteoarthritis; Pathogenesis; Reactive arthritis; Rheumatoid arthritis; T cell; TNF

Indexed keywords

ANTIRHEUMATIC AGENT; CYTOKINE; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOKINE; LYMPHOTOXIN; MONOKINE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; REACTIVE ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; CYTOKINES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-2; MALE; MIDDLE AGED; PHENOTYPE; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; T-LYMPHOCYTE SUBSETS;

EID: 0032703306     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.3.202     Document Type: Article

References (74)

1. Feldmann M, Dower S, Brennan FM. The role of cytokines in normal and pathological situations. In: Brennan FM, Feldmann M, eds. Cytokines in autoimmunity. Austin: RG Landes Co., 1996:1-24.
2. Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
3. Brennan FM, Maini RN, Feldmann M. Cytokines in rheumatoid arthritis. In: Brennan FM, Feldmann M, eds. Cytokines in autoimmunity. Austin: RG Landes Co., 1996:25-48.
4. Koch AE, Kunkel SL, Stricter RM. Cylokines in rheumatoid arthritis. J Invest Med 1995;43:28-38.
5. Pitzalis C, Kingsley G, Lanchbury JS, Murphy J, Panayi GS. Expression of HLA-DR, DQ and DP antigens and interleukin-2 receptor on synovial fluid T lymphocyte subsets in rheumatoid arthritis: evidence for 'frustrated' activation. J Rheumatol 1987;14:662-6.
6. Smith MD, O'Donnell J, Highton J, Palmer DG, Rozenbilds M, Roberts Thomson PJ. Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: scarcity of CD5 positive B cells and IL2 receptor bearing T cells. Pathology 1992;24:19-26.
7. Firestein GS, Zvaifler NJ. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor. Arthritis Rheum 1987;30:864-71.
8. Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
9. Firestein GS, Xu WD, Townsend K, Broide D, Alvaro-Gracia J. Glasebrook A et al. Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-I) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med 1988;168:1573-86.
10. Firestein GS, Alvaro-Garcia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.
11. Holt I, Cooper RG, Denton J, Meager A, Hopkins SJ. Cytokine inter-relationships and their associations with disease activity in arthritis. Br J Rheumatol 1992; 31:725-33.
12. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 1990; 33:768-73.
13. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. [Editorial] Arthritis Rheum 1992;35:729-35.
14. Smolen JS, Tohidast-Akrad M, Gal A, Kunaver M, Eberl G, Zenz P et al. The role of T lymphocytes and cytokines in rheumatoid arthritis. Scand J Rheumatol 1996;25:1-4.
15. Fox DA. The role of T cells in the immunopathogenesis of rheumatoid arthritis. Arthritis Rheum 1997;40:598-609.
16. Breedveld FC, Verweij CL. T cells in rheumatoid arthritis. [Editorial] Br J Rheumatol 1997;36:617-21.
17. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Steiner G, Studnicka-Benke A, Witzmann G, Höfier E, Smolen JS. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis. J Rheumatol 1995;22:406-12.
19. Studnicka-Benke A, Steiner G, Petera P, Smolen JS. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996;35:1067-74.
20. Roux-Lombard P, Steiner G and the Cytokine Consensus Group of the European Workshop for Rheumatology Research. Preliminary report on cytokine determination in human synovial fluids: a consensus study of the European Workshop for Rheumatology Research. Clin Exp Rheumatol 1992;10:515-20.
21. Chu CQ, Field M, Fcldmann M, Maini RN. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
22. Ulfgren AK. Lindblad S, Klareskog L, Andcrsson J, Andersson U. Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:654-61.
23. Warren CJ, Howell WM, Bhambhani M, Cawley MID, Smith JL. An investigation of T-cell subset phenotype and function in the rheumatoid synovium using in situ hybridization for IL-2 mRNA. Immunology 1991;72:250-5.
24. Chen E, Keystone EC, Fish EN. Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 1992;36:901-10.
25. Dolhain RJEM, ter Haar NT. de Kuiper R et al. Distribution of T cells and signs of T cell activation in the rheumatoid joint: implications for semiquantative comparative histology. Br J Rheumatol 1998;37:324-30.
26. Fitzgerald JE, Ricalton NS, Meyer A, West SG, Kaplan H, Behrendt C el al. Analysis of clonal CDS+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol 1995;154:3538-47.
27. Burmester GR, Daser A, Kamradt T, Krause A, Mitchison NA, Sieper J et al. Immunology of reactive arthritides. Annu Rev Immunol 1995;13:229-50.
28. Simon AK, Seipelt E, Sieper J. Divergent T cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994;91:8562-6.
29. Woloszczuk W, Schwarz M, Havel M, Laczkovics A, Muller MM. Neopterin and interferon gamma serum levels in patients with heart and kidney transplants. J Clin Chem Cin Biochem 1986;24:729-34.
30. Philip R, Epstein LB. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interlcukin-1. Nature 1986;323:86-9.
31. Corradin SB, Buchmuller-Rouiller Y, Mauel J. Phagocytosis enhances murine macrophage activation by interferon-gamma and tumor necrosis factor-alpha. Eur J Immunol 1991;21:2553-8.
32. Myers MJ, Ghildyal N, Schook LB. Endotoxin and interferon-gamma differentially regulate the transcriptional levels of proto-oncogenes and cytokine genes during the differentiation of colony-stimulating factor type-1-derived macrophages. Immunology 1995;85:318-24.
33. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immimol 1994;12:227-58.
34. Nicholson LB, Kuchroo VK. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 1996;8:837-42.
35. Miltenburg AMM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 1992;35:603-10.
36. Quayle AJ, Chomarat P, Miossec P, Kjeldsen-Kragh J, Forre O, Natvig JB. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 1993;38:75-82.
37. Dolhain RJEM, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AMM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1961-9.
38. Van Roon JAG, van Roy JLAM, Gmelig-Meyling FHJ, Lafeber FP, Bijlsma JWJ. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.
39. Müssener A, Lorentzen JC, Kleinau S, Klareskog L. Altered Th1/Th2 balance associated with non-major histocompatibility complex genes in collagen-induced arthritis in resistant and non-resistant rat strains. Eur J Immunol 1997;27:695-9.
40. Zvaifler NJ, Firestein GS. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 1994;37:783-9.
41. Burmester GR, Suhlmüller B, Keyszer G, Kinne RW. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum 1997;40:5-18.
42. Müller-Ladner U. Molecular and cellular interactions in rheumatoid synovium. Curr Opin Rheumatol 1996;8:210-20.
43. Steinman L. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci USA 1996;93:2253-6.
44. Marchal G, Seman M, Milon G, Truffa-Bachi P, Zilberfarb V. Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J Immunol 1982;129:954-8.
45. Modlin RL, Melancon-Kaplan J, Young SM et al. Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci USA 1988;85:1213-7.
46. Kalish RS, Johnson KL. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in allergic contact dermatitis to urushiol. J Immunol 1990;145:3706-13.
47. Sun J, Link H, Olsson T et al T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 1991;146:1490-5.
48. Weyand C, Oppitz U, Hicok K, Goronczy JJ. Selection of T cell receptor Vβ elements by HLA-DR determinants predisposing to rheumatoid arthritis. Arthritis Rheum 1992;35:90-8.
49. Tak PP, Smeets TJM, Daha MR, Kluin PM, Meijersw KAE, Brand R et al. Analysis of the synovial cellular infiltrate in early rheumatoid synovial tissue in relation to disease activity. Arthritis Rheum 1997;40:217-25.
50. Maurer D, Felzmann T, Holter W, Petera P, Smolen J, Knapp W. Evidence for the presence of activated CD4 T cells with naive phenotype in the peripheral blood of patients with rheumatoid arthritis. Clin Exp Immunol 1992;87:429-34.
51. Ikeda Y, Masuko K, Nakai Y et al. High frequencies of identical T cell clonotypes in synovial tissues of rheumatoid arthritis patients suggest the occurrence of common antigen-driven immune responses. Arthritis Rheum 1996;39:446-53.
52. Gonzalez-Quintial R, Baccala R, Pope RM, Theofilopoulos AN. Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay. J Clin Invest 1996;97:1335-43.
53. Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7-CD28 -T cells are expanded in rheumatoid arthritis and are characterized by autoreactivhy. J Clin Invest 1996;97:2027-37.
54. Rittner HL, Zettl A, Jendro MC, Bartzbazzanella P, Goronzy JJ, Weyand CM. Multiple mechanisms support oligoclonal T cell expansion in rheumatoid synovitis. Mol Med 1997;3:452-65.
55. Berek C, Schroder AE. A germinal center-like reaction in the nonlymphoid tissue of the synovial membrane. Ann NY Acad Sci 1997;815:211-7.
56. Tugwell P. Cyclosporin in rheumatoid arthritis: documented efficacy and safety. Semin Arthritis Rheum 1992;21:30-8.
57. Horneff G, Sack U, Kalden JR, Emmrich F, Burmester GR. Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. Clin Exp Immunol 1993;91:207-13.
58. Tak PP, van der Lubbe PA, Cauli A et al. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 1995;38:1457-65.
59. Choy EH, Pitzalis C, Cauli A et al. Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens. Arthritis Rheum 1996;39:52-6.
60. Epstein WV. Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience. Arthritis Rheum 1996;39:1773-80.
61. Ridgeway W, Fathman CG. Anti-CD4 in the treatment of rheumatoid arthritis - a reappraisal. Immunologist 1996;4:203-6.
62. Mclnnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nature Med 1997;3:189-95.
63. Sebbag M, Parry SL, Brennan FM, Feldmann M. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-α, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis. Eur J Immunol 1997;27:624-32.
64. Parry SL, Sebbag M, Feldmann M, Brennan FM. Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF alpha. J Immunol 1997;158:3673-81.
65. Müssener A, Litton MJ, Lindroos E, Klareskog L. Cytokine production in synovial tissue of mice with collagen-induced arthritis. Clin Exp Immunol 1997;107:485-93.
66. Marinova-Mutafchieva L, Williams R-O, Mason LJ, Mauri C, Feldmann M, Maini RN. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin Exp Immunol 1997;107:507-12.
67. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996;87:811-22.
68. Cope AP, Londei M, Chu NR et al. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest 1994;94:749-60.
69. Katsikis PD, Chu C-Q, Brennan FM, Maini RN, Feldmann M. Immunoregulalory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
70. Cush JC, Splawski JB, Thomas R et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:96-104.
71. Williams RO, Mason LJ, Feldmann M, Maini RN. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of collagen-induced arthritis. Proc Nail Acad Sci USA 1994;91:2762-6.
72. Tugwcll P, Pincus T, Yocum D et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The methotrexate-cyclosporine combination study group. N Engl J Med 1995;333:137-41.
73. Kalden JR, Manger B. Biologic agents in the treatment of inflammatory rheumatic diseases. Curr Opin Rheumatol 1995;7:191-7.
74. Rep MHG, van Oosten BW, Roos MTL, Adèr HJ, Polman CH, van Lier RAW. Treatment with depleting CD4 monoclonal antibody results in preferential loss of circulating naive T cells but does not affect IFN-γ secreting Th1 cells in humans. J Clin Invest 1997;99:2225-32.